: MIDRANGE dot COM Mailing List Archive

Re: No vaccine


AddThis Feed Button


Bullshit, Norm, Why would you say something that stupid?

This is obviously over the top, an administrator trying to remove all
possible threats against the students he's responsible for, common sense be
damned. It's ridiculous. This is on a level with that instance where the
girl was suspended for bringing aspirin to school. Why on earth do you
think I would be in favor of such a thing?

On the discipline front, what do you suggest? Floggings? The schools do
what they are allowed to do by way of discipline, trust me.

It seems to me that you and that jerk from TX who apparently started this
thread haven't set foot in a public school in a long, long time. Don't
write about things you have no clue about. It's a waste of everyone's time.



-----Original Message-----
From: cpf0000-bounces@xxxxxxxxxxxx [mailto:cpf0000-bounces@xxxxxxxxxxxx] On
Behalf Of Norm Dennis
Sent: Monday, October 12, 2009 10:00 PM
To: 'Open discussion among iSeries Users'
Subject: Re: [CPF0000] No vaccine


More left-wing wacko PC BS, Terry will be delighted.

Hey, here's an idea, maybe the authorities should try some basic discipline,
instead of the PC BS. Oh, that's right they don't have balls or brains to
make commonsense decisions anymore.


Norm Dennis

-----Original Message-----
From: cpf0000-bounces@xxxxxxxxxxxx [mailto:cpf0000-bounces@xxxxxxxxxxxx] On
Behalf Of Paul Nelson
Sent: Tuesday, 13 October 2009 3:34 AM
To: 'Open discussion among iSeries Users'
Subject: [CPF0000] No vaccine

http://www.nytimes.com/2009/10/12/education/12discipline.html?no_interstitia
l
http://preview.tinyurl.com/yzvu3sp


Paul Nelson
Office 512-392-2577
Cell 708-670-6978
nelsonp@xxxxxxxxxxxxx








Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2010 by MIDRANGE dot COM and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available here. If you have questions about this, please contact